论文信息 - Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset - 字舞流文

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

K. Kiura | M. Satouchi | S. Matsumoto | M. Nishio | I. Okamoto | M. Takenoyama | K. Nakagawa | T. Kurata | T. Hida | H. Kagamu | F. Imamura | Y. Fujisaka | B. Hatano | K. Tokushige | Masayuki Ito